Family Medicine Doctors in Beeville, TX Accepting Medicare

8 Family Medicine doctors found. Showing 1 - 8

Dr. Joseph A Larakers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 302 S Hillside Dr, Beeville, TX 78102 Phone: 361-358-2392    Fax: 361-358-7640

Dr. Francisco J Calica, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 711 E Houston St, Beeville, TX 78102 Phone: 361-358-1000    Fax: 361-358-1015

Bridgett Dean, FNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1402 E Houston St, Beeville, TX 78102 Phone: 361-362-9711

Georgiy Tsisnevich, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1500 E Houston St, Beeville, TX 78102 Phone: 361-354-2000

Karl V Stein, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 191 Oak Hill Dr, Beeville, TX 78102 Phone: 361-563-8010

John Wenhold, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 E Houston St, Beeville, TX 78102 Phone: 361-354-2000

Dr. Karole L Beasley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1602 E Houston St, Suite C, Beeville, TX 78102 Phone: 361-358-9200    Fax: 361-362-1717

Dr. Frank Raymond Dehnisch Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1602 E Houston St, Suite C, Beeville, TX 78102 Phone: 361-358-9200    Fax: 361-358-5513

News Archive

Study links spinal muscular atrophy disease expression with haplotypes

A natural history study has provided the first comprehensive clinical description of spinal muscular atrophy within the Amish and Mennonite communities and correlates ancestral chromosome 5 haplotypes and SMN2 copy number with disease severity.

Study reveals that brain cancer cells resist therapy by dialing down gene mutation targeted by drugs

A team of scientists, led by principal investigator Paul S. Mischel, MD, a member of the Ludwig Institute for Cancer Research and professor in the Department of Pathology at the University of California, San Diego School of Medicine, has found that brain cancer cells resist therapy by dialing down the gene mutation targeted by drugs, then re-amplify that growth-promoting mutation after therapy has stopped.

NASDAQ notifies CytRx of non-compliance with minimum bid price requirement

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that, as anticipated, on February 15, 2012, the Company was notified by The NASDAQ Stock Market that because the Company has not regained compliance with the $1.00 minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2), the Company's common stock would be subject to delisting from The NASDAQ Capital Market unless the Company requests a hearing before a NASDAQ Hearings Panel.

Minimally invasive valve replacement appears to provide durable remedy for people with heart disease

A minimally invasive procedure used to replace heart valves without open heart surgery appears to provide a durable remedy for people with a life-threatening form of heart disease in which the aortic valve opening narrows, diminishing blood flow.

Read more Medical News

› Verified 1 days ago